Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

PTC THERAPEUTICS INC (PTCT)

338 + Investors. Track Smart Money conviction in PTCT. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +53
Streak
8Q ▲
Buyers last Q
62%

Smart Money Signals — PTCT

Based on 326 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 8 quarters in a row

last 6Q
For 8 consecutive quarters, more hedge funds added PTCT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
326 hedge funds hold PTCT right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +44% more funds vs a year ago

fund count last 6Q
+100 new funds entered over the past year (+44% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 62% buying

216 buying133 selling
Last quarter: 216 funds were net buyers (95 opened a brand new position + 121 added to an existing one). Only 133 were sellers (91 trimmed + 42 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+44 vs last Q)

new funds entering per quarter
Funds opening a new PTCT position: 51 → 53 → 51 → 95. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

47% of holders stayed for 2+ years

47% conviction (2yr+) 20% medium 34% new
152 out of 326 hedge funds have held PTCT for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +36% but shares only +10% — price-driven

Value
+36%
Shares
+10%
Last quarter: the total dollar value of institutional holdings rose +36%, but actual share count only changed +10%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
📈

Growing discovery — still being found

51 → 51 → 53 → 51 → 95 new funds/Q
New funds entering each quarter: 51 → 53 → 51 → 95. A growing number of institutions are discovering PTCT each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Deep conviction — 56% of holders stayed 2+ years

56% veterans 9% 1-2yr 35% new
Of 338 current holders: 189 (56%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
🏆

Elite ownership — 41% AUM from top-100 funds

41% from top-100 AUM funds
38 of 326 holders are among the 100 largest funds by AUM, controlling 41% of total institutional value in PTCT. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
4.3
out of 10
Moderate Exit Risk
Exit risk score 4.3/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — PTCT

In 2025 Q4, 216 hedge funds were net buyers of PTCT (95 opened a new position, 121 added to an existing one), while 133 reduced or exited (91 trimmed, 42 sold completely) — a 62% buyer ratio, indicating clear institutional accumulation. This marks 8 consecutive quarters of net institutional buying — a persistent conviction signal. 41% of total institutional value in PTCT is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +53 funds (more new holders than closures). Total institutional holders: 326.

Hedge Fund Ownership: PTCT

How many hedge funds hold PTCT — quarterly history vs. share price
Quarterly hedge fund ownership of PTCT vs. share price

Market Analysis: PTCT

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: PTCT

Healthcare Biotechnology

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Smart Money Signal ?
Broad Consensus, Selective Conviction

Many quality funds hold this stock, but top-tier positions remain relatively small.

51 top-rated funds 3 high-conviction
Consensus
7.5
/ 10
breadth
×
Elite
2.3
/ 10
conviction
Hedge Fund Positioning: PTCT
2026 Q1 Stats Unlock in 6 days 338 + Investors

Track Smart Money conviction in PTCT. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 338 286 18.18%
13F Shares 92M 83M 10.18%
Total Value $6.94B $5.09B 36.44%
New Positions 95 55 +40
Increased Positions 137 112 +25
Closed Positions 43 42 +1
Reduced Positions 112 113 -1
Total Calls 7 9 -22.22%
Total Puts 6 6 -
PUT/CALL Ratio 0.86 0.67 Neutral

Statistics: PTCT

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

338 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in PTCT. Verified SEC 13F-HR filings.

Top 25 institutional holders of PTCT — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 SECTOR GAMMA AS 1.21% 75,000 $5.1M
2 Jefferies Financial Group Inc. 0.63% 1,354,459 $92.3M
3 Private Capital Advisors, Inc. 0.30% 38,983 $2.7M
4 Convergence Investment Partners, LLC 0.30% 27,219 $1.9M
5 PSP Research LLC 0.29% 6,000 $409K
6 JUPITER ASSET MANAGEMENT LTD 0.26% 711,457 $48.5M
7 Stirlingshire Investments, Inc. 0.22% 3,718 $253K
8 Phocas Financial Corp. 0.21% 19,875 $1.4M
9 CenterBook Partners LP 0.21% 56,813 $3.9M
10 Measured Wealth Private Client Group, LLC 0.14% 7,395 $504K
11 Catalyst Funds Management Pty Ltd 0.13% 11,200 $763K
12 JUNCTURE WEALTH STRATEGIES, LLC 0.12% 5,148 $351K
13 SIERRA SUMMIT ADVISORS LLC 0.12% 11,790 $803K
14 denkapparat Operations GmbH 0.09% 3,290 $224K
15 Pictet Asset Management Holding SA 0.08% 1,183,720 $80.1M
16 PROFUND ADVISORS LLC 0.08% 33,326 $2.3M
17 Gallacher Capital Management LLC 0.08% 3,019 $206K
18 MARTINGALE ASSET MANAGEMENT L P 0.08% 45,507 $3.1M
19 China Universal Asset Management Co., Ltd. 0.08% 14,689 $1.0M
20 GLOBEFLEX CAPITAL L P 0.08% 7,290 $497K
21 Ensign Peak Advisors, Inc 0.07% 582,318 $39.7M
22 PUBLIC SECTOR PENSION INVESTMENT BOARD 0.07% 331,852 $22.6M
23 Abel Hall, LLC 0.07% 4,562 $311K
24 PINNACLE ASSOCIATES LTD 0.07% 74,956 $5.1M
25 SG Americas Securities, LLC 0.06% 879,701 $60K
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — PTC THERAPEUTICS INC (PTCT)

What does the Smart Money Trend signal show for PTCT?

Buying streak — 8 quarters in a row: For 8 consecutive quarters, more hedge funds added PTCT than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for PTCT?

More buyers than sellers — 62% buying: Last quarter: 216 funds were net buyers (95 opened a brand new position + 121 added to an existing one). Only 133 were sellers (91 trimmed + 42 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for PTCT holders?

Elite ownership — 41% AUM from top-100 funds: 38 of 326 holders are among the 100 largest funds by AUM, controlling 41% of total institutional value in PTCT. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held PTCT?

47% of holders stayed for 2+ years: 152 out of 326 hedge funds have held PTCT for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.